Twist Bioscience
TWST
TWST
217 hedge funds and large institutions have $2.5B invested in Twist Bioscience in 2023 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 55 increasing their positions, 75 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.9% more ownership
Funds ownership: 114.81% → 117.71% (+2.9%)
21% less call options, than puts
Call options by funds: $11.8M | Put options by funds: $15M
27% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 75
Holders
217
Holding in Top 10
2
Calls
$11.8M
Puts
$15M
Top Buyers
| 1 | +$72.3M | |
| 2 | +$42.9M | |
| 3 | +$31.9M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$15.7M |
| 5 |
Man Group
London,
United Kingdom
|
+$10.7M |
Top Sellers
| 1 | -$73.5M | |
| 2 | -$23.5M | |
| 3 | -$19.5M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$16.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$13.1M |